Literature DB >> 10346865

Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.

D L Ladd1, R Hollister, X Peng, D Wei, G Wu, D Delecki, R A Snow, J L Toner, K Kellar, J Eck, V C Desai, G Raymond, L B Kinter, T S Desser, D L Rubin.   

Abstract

We have synthesized and evaluated five series of polymeric gadolinium chelates which are of interest as potential MRI blood pool contrast agents. The polymers were designed so that important physical properties including molecular weight, relaxivity, metal content, viscosity, and chelate stability could be varied. We have shown that, by selecting polymers of the appropriate MW, extended blood pool retention can be achieved. In addition, relaxivity can be manipulated by changing the polymer rigidity, metal content affected by monomer selection, viscosity by polymer shape, and chelate stability by chelator selection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346865     DOI: 10.1021/bc980086+

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  15 in total

1.  Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.

Authors:  Kannika Khantasup; Pairash Saiviroonporn; Suwatchai Jarussophon; Warangkana Chantima; Tararaj Dharakul
Journal:  MAGMA       Date:  2018-05-08       Impact factor: 2.310

2.  Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.

Authors:  Todd L Kaneshiro; Tianyi Ke; Eun-Kee Jeong; Dennis L Parker; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2006-06-01       Impact factor: 4.200

Review 3.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Macromolecular and dendrimer-based magnetic resonance contrast agents.

Authors:  Ambika Bumb; Martin W Brechbiel; Peter Choyke
Journal:  Acta Radiol       Date:  2010-09       Impact factor: 1.990

5.  Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.

Authors:  Xinghe Wang; Yi Feng; Tianyi Ke; Matthias Schabel; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

6.  Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents.

Authors:  P L Anelli; L Lattuada; V Lorusso; M Schneider; H Tournier; F Uggeri
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

7.  The degradation and clearance of Poly(N-hydroxypropyl-L-glutamine)-DTPA-Gd as a blood pool MRI contrast agent.

Authors:  Guodong Zhang; Rui Zhang; Marites P Melancon; Kelvin Wong; Jian You; Qian Huang; James Bankson; Dong Liang; Chun Li
Journal:  Biomaterials       Date:  2012-04-26       Impact factor: 12.479

8.  Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging.

Authors:  Zhen Ye; Xueming Wu; Mingqian Tan; Jack Jesberger; Mark Grisworld; Zheng-Rong Lu
Journal:  Contrast Media Mol Imaging       Date:  2013 May-Jun       Impact factor: 3.161

9.  Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?

Authors:  Joshua Bryson; Jeffrey W Reineke; Theresa M Reineke
Journal:  Macromolecules       Date:  2012-11-13       Impact factor: 5.985

10.  Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.

Authors:  Todd Lyle Kaneshiro; Eun-Kee Jeong; Glen Morrell; Dennis L Parker; Zheng-Rong Lu
Journal:  Biomacromolecules       Date:  2008-09-05       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.